nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—SCN5A—SIDS Susceptibility Pathways—AR—hematologic cancer	0.000405	0.00258	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ARHGEF12—hematologic cancer	0.000405	0.00257	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—TRIO—hematologic cancer	0.0004	0.00254	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CCND3—hematologic cancer	0.000397	0.00253	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—PTPRC—hematologic cancer	0.000394	0.00251	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—RAC2—hematologic cancer	0.000384	0.00244	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CCND3—hematologic cancer	0.000381	0.00243	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MYH11—hematologic cancer	0.000376	0.00239	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CNTN2—hematologic cancer	0.000376	0.00239	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—HSP90AA1—hematologic cancer	0.000372	0.00236	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—RAC2—hematologic cancer	0.000369	0.00235	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CCND3—hematologic cancer	0.000368	0.00234	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NCOA3—hematologic cancer	0.000367	0.00233	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—SRC—hematologic cancer	0.000366	0.00233	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—HSP90AA1—hematologic cancer	0.000357	0.00227	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NCAM1—hematologic cancer	0.000357	0.00227	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—HES1—hematologic cancer	0.000356	0.00227	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—RAC2—hematologic cancer	0.000356	0.00226	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL10—hematologic cancer	0.000354	0.00225	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—AGRN—hematologic cancer	0.000354	0.00225	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NCOA3—hematologic cancer	0.000353	0.00224	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—SRC—hematologic cancer	0.000351	0.00223	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—RAC2—hematologic cancer	0.00035	0.00223	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—HSP90AA1—hematologic cancer	0.000344	0.00219	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—MAP2K1—hematologic cancer	0.000343	0.00218	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NCAM1—hematologic cancer	0.000343	0.00218	CbGpPWpGaD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—hematologic cancer	0.000342	0.00218	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NCOA3—hematologic cancer	0.00034	0.00216	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—SRC—hematologic cancer	0.000339	0.00215	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CTNNA1—hematologic cancer	0.000338	0.00215	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—MAPK3—hematologic cancer	0.000337	0.00214	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CEBPA—hematologic cancer	0.000335	0.00213	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CEBPD—hematologic cancer	0.000335	0.00213	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—GRB2—hematologic cancer	0.000335	0.00213	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NCAM1—hematologic cancer	0.000331	0.0021	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—TIAM1—hematologic cancer	0.00033	0.0021	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—NR3C1—hematologic cancer	0.000328	0.00208	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—NCAM1—hematologic cancer	0.000326	0.00207	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CTNNA1—hematologic cancer	0.000324	0.00206	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—MAPK3—hematologic cancer	0.000324	0.00206	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—ABL1—hematologic cancer	0.000322	0.00205	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—GRB2—hematologic cancer	0.000322	0.00205	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CTNNA1—hematologic cancer	0.000313	0.00199	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—MAPK3—hematologic cancer	0.000312	0.00199	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—GRB2—hematologic cancer	0.000311	0.00198	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—ABL1—hematologic cancer	0.00031	0.00197	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PTPRC—hematologic cancer	0.000304	0.00193	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NCOR2—hematologic cancer	0.000303	0.00193	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—ABL1—hematologic cancer	0.000299	0.0019	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—PTPRC—hematologic cancer	0.000292	0.00185	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—JAK1—hematologic cancer	0.000289	0.00184	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—TRIO—hematologic cancer	0.000285	0.00181	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—PTPRC—hematologic cancer	0.000281	0.00179	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—JAK1—hematologic cancer	0.000278	0.00177	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—PTPRC—hematologic cancer	0.000277	0.00176	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—JAK1—hematologic cancer	0.000268	0.0017	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—HSP90AA1—hematologic cancer	0.000265	0.00169	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CCND3—hematologic cancer	0.000259	0.00164	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—HSP90AA1—hematologic cancer	0.000255	0.00162	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CREB1—hematologic cancer	0.00025	0.00159	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—RAC2—hematologic cancer	0.00025	0.00159	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—HSP90AA1—hematologic cancer	0.000246	0.00156	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL6R—hematologic cancer	0.000244	0.00155	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	0.000244	0.00155	CbGpPWpGaD
Prilocaine—Hypotension—Cisplatin—hematologic cancer	0.000243	0.000288	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—HSP90AA1—hematologic cancer	0.000242	0.00154	CbGpPWpGaD
Prilocaine—Urticaria—Alitretinoin—hematologic cancer	0.000242	0.000287	CcSEcCtD
Prilocaine—Vomiting—Hydroxyurea—hematologic cancer	0.000242	0.000287	CcSEcCtD
Prilocaine—Confusional state—Etoposide—hematologic cancer	0.00024	0.000285	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—GRB2—hematologic cancer	0.000239	0.00152	CbGpPWpGaD
Prilocaine—Urticaria—Ifosfamide—hematologic cancer	0.000239	0.000284	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—MET—hematologic cancer	0.000239	0.00152	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NCOA3—hematologic cancer	0.000239	0.00152	CbGpPWpGaD
Prilocaine—Cardiac arrest—Doxorubicin—hematologic cancer	0.000239	0.000283	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—SRC—hematologic cancer	0.000238	0.00151	CbGpPWpGaD
Prilocaine—Pain—Gemcitabine—hematologic cancer	0.000238	0.000283	CcSEcCtD
Prilocaine—Anaphylactic shock—Etoposide—hematologic cancer	0.000238	0.000282	CcSEcCtD
Prilocaine—Asthenia—Thiotepa—hematologic cancer	0.000238	0.000282	CcSEcCtD
Prilocaine—Syncope—Triamcinolone—hematologic cancer	0.000237	0.000281	CcSEcCtD
Prilocaine—Hypersensitivity—Thalidomide—hematologic cancer	0.000236	0.00028	CcSEcCtD
Prilocaine—Nausea—Melphalan—hematologic cancer	0.000236	0.00028	CcSEcCtD
Prilocaine—Feeling abnormal—Irinotecan—hematologic cancer	0.000236	0.00028	CcSEcCtD
Prilocaine—Feeling abnormal—Mitoxantrone—hematologic cancer	0.000236	0.00028	CcSEcCtD
Prilocaine—Dizziness—Bortezomib—hematologic cancer	0.000235	0.000279	CcSEcCtD
Prilocaine—Oedema—Prednisolone—hematologic cancer	0.000235	0.000278	CcSEcCtD
Prilocaine—Anaphylactic shock—Prednisolone—hematologic cancer	0.000235	0.000278	CcSEcCtD
Prilocaine—Paraesthesia—Cisplatin—hematologic cancer	0.000233	0.000277	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—NCAM1—hematologic cancer	0.000232	0.00148	CbGpPWpGaD
Prilocaine—Loss of consciousness—Triamcinolone—hematologic cancer	0.000232	0.000276	CcSEcCtD
Prilocaine—Shock—Prednisolone—hematologic cancer	0.000231	0.000274	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—ABL1—hematologic cancer	0.00023	0.00146	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—GRB2—hematologic cancer	0.00023	0.00146	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Etoposide—hematologic cancer	0.00023	0.000273	CcSEcCtD
Prilocaine—Asthenia—Thalidomide—hematologic cancer	0.00023	0.000273	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—MET—hematologic cancer	0.00023	0.00146	CbGpPWpGaD
Prilocaine—Feeling abnormal—Gemcitabine—hematologic cancer	0.000229	0.000272	CcSEcCtD
Prilocaine—Dizziness—Vinorelbine—hematologic cancer	0.000229	0.000272	CcSEcCtD
Prilocaine—Nausea—Lenalidomide—hematologic cancer	0.000229	0.000272	CcSEcCtD
Prilocaine—Hypertension—Triamcinolone—hematologic cancer	0.000228	0.000271	CcSEcCtD
Prilocaine—Urticaria—Mitoxantrone—hematologic cancer	0.000227	0.000269	CcSEcCtD
Prilocaine—Hyperhidrosis—Prednisolone—hematologic cancer	0.000227	0.000269	CcSEcCtD
Prilocaine—Hypersensitivity—Carmustine—hematologic cancer	0.000227	0.000269	CcSEcCtD
Prilocaine—Nausea—Hydroxyurea—hematologic cancer	0.000226	0.000268	CcSEcCtD
Prilocaine—Vomiting—Bortezomib—hematologic cancer	0.000226	0.000268	CcSEcCtD
Prilocaine—Hypersensitivity—Alitretinoin—hematologic cancer	0.000224	0.000266	CcSEcCtD
Prilocaine—Vomiting—Bleomycin—hematologic cancer	0.000224	0.000266	CcSEcCtD
Prilocaine—Drowsiness—Methotrexate—hematologic cancer	0.000223	0.000265	CcSEcCtD
Prilocaine—Hypotension—Etoposide—hematologic cancer	0.000222	0.000264	CcSEcCtD
Prilocaine—Pain—Cisplatin—hematologic cancer	0.000222	0.000263	CcSEcCtD
Prilocaine—Hypersensitivity—Ifosfamide—hematologic cancer	0.000222	0.000263	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—GRB2—hematologic cancer	0.000222	0.00141	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MET—hematologic cancer	0.000221	0.00141	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—PTPN11—hematologic cancer	0.000221	0.00141	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—ABL1—hematologic cancer	0.000221	0.00141	CbGpPWpGaD
Prilocaine—Asthenia—Carmustine—hematologic cancer	0.000221	0.000262	CcSEcCtD
Prilocaine—Vomiting—Vinorelbine—hematologic cancer	0.00022	0.000262	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—CTNNA1—hematologic cancer	0.00022	0.0014	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—MAPK3—hematologic cancer	0.000219	0.0014	CbGpPWpGaD
Prilocaine—Dizziness—Thiotepa—hematologic cancer	0.000219	0.00026	CcSEcCtD
Prilocaine—Asthenia—Alitretinoin—hematologic cancer	0.000219	0.000259	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—GRB2—hematologic cancer	0.000218	0.00139	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—HES1—hematologic cancer	0.000218	0.00138	CbGpPWpGaD
Prilocaine—Hypersensitivity—Vincristine—hematologic cancer	0.000216	0.000257	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NCOR1—hematologic cancer	0.000216	0.00138	CbGpPWpGaD
Prilocaine—Asthenia—Ifosfamide—hematologic cancer	0.000216	0.000256	CcSEcCtD
Prilocaine—Oedema—Triamcinolone—hematologic cancer	0.000216	0.000256	CcSEcCtD
Prilocaine—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000216	0.000256	CcSEcCtD
Prilocaine—Syncope—Betamethasone—hematologic cancer	0.000215	0.000255	CcSEcCtD
Prilocaine—Syncope—Dexamethasone—hematologic cancer	0.000215	0.000255	CcSEcCtD
Prilocaine—Arrhythmia—Prednisone—hematologic cancer	0.000214	0.000254	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—CREB1—hematologic cancer	0.000214	0.00136	CbGpPWpGaD
Prilocaine—Sweating—Methotrexate—hematologic cancer	0.000214	0.000254	CcSEcCtD
Prilocaine—Feeling abnormal—Cisplatin—hematologic cancer	0.000214	0.000254	CcSEcCtD
Prilocaine—Paraesthesia—Etoposide—hematologic cancer	0.000214	0.000253	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—ABL1—hematologic cancer	0.000213	0.00136	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—PTPN11—hematologic cancer	0.000212	0.00135	CbGpPWpGaD
Prilocaine—Shock—Triamcinolone—hematologic cancer	0.000212	0.000252	CcSEcCtD
Prilocaine—Dizziness—Thalidomide—hematologic cancer	0.000212	0.000251	CcSEcCtD
Prilocaine—Somnolence—Etoposide—hematologic cancer	0.000211	0.000251	CcSEcCtD
Prilocaine—Nausea—Bortezomib—hematologic cancer	0.000211	0.00025	CcSEcCtD
Prilocaine—Loss of consciousness—Dexamethasone—hematologic cancer	0.000211	0.00025	CcSEcCtD
Prilocaine—Loss of consciousness—Betamethasone—hematologic cancer	0.000211	0.00025	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—FOXO1—hematologic cancer	0.000211	0.00134	CbGpPWpGaD
Prilocaine—Hypersensitivity—Irinotecan—hematologic cancer	0.000211	0.00025	CcSEcCtD
Prilocaine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000211	0.00025	CcSEcCtD
Prilocaine—Asthenia—Vincristine—hematologic cancer	0.000211	0.00025	CcSEcCtD
Prilocaine—Paraesthesia—Prednisolone—hematologic cancer	0.000211	0.00025	CcSEcCtD
Prilocaine—Vomiting—Thiotepa—hematologic cancer	0.00021	0.00025	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—ABL1—hematologic cancer	0.00021	0.00134	CbGpPWpGaD
Prilocaine—Nausea—Bleomycin—hematologic cancer	0.000209	0.000248	CcSEcCtD
Prilocaine—Drowsiness—Epirubicin—hematologic cancer	0.000209	0.000248	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—HES1—hematologic cancer	0.000209	0.00133	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—IL6R—hematologic cancer	0.000209	0.00133	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000209	0.000247	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—NCOR1—hematologic cancer	0.000208	0.00132	CbGpPWpGaD
Prilocaine—Hypertension—Dexamethasone—hematologic cancer	0.000207	0.000246	CcSEcCtD
Prilocaine—Hypertension—Betamethasone—hematologic cancer	0.000207	0.000246	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—JAK1—hematologic cancer	0.000206	0.00131	CbGpPWpGaD
Prilocaine—Nausea—Vinorelbine—hematologic cancer	0.000206	0.000244	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—CREB1—hematologic cancer	0.000206	0.00131	CbGpPWpGaD
Prilocaine—Asthenia—Irinotecan—hematologic cancer	0.000205	0.000243	CcSEcCtD
Prilocaine—Asthenia—Mitoxantrone—hematologic cancer	0.000205	0.000243	CcSEcCtD
Prilocaine—Neuropathy peripheral—Epirubicin—hematologic cancer	0.000205	0.000243	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—PTPN11—hematologic cancer	0.000205	0.0013	CbGpPWpGaD
Prilocaine—Vomiting—Thalidomide—hematologic cancer	0.000204	0.000242	CcSEcCtD
Prilocaine—Anxiety—Betamethasone—hematologic cancer	0.000203	0.000241	CcSEcCtD
Prilocaine—Anxiety—Dexamethasone—hematologic cancer	0.000203	0.000241	CcSEcCtD
Prilocaine—Dizziness—Carmustine—hematologic cancer	0.000203	0.000241	CcSEcCtD
Prilocaine—Pain—Etoposide—hematologic cancer	0.000203	0.000241	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—FOXO1—hematologic cancer	0.000202	0.00129	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—HES1—hematologic cancer	0.000202	0.00128	CbGpPWpGaD
Prilocaine—Dizziness—Alitretinoin—hematologic cancer	0.000201	0.000239	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—IL6R—hematologic cancer	0.000201	0.00128	CbGpPWpGaD
Prilocaine—Pain—Prednisolone—hematologic cancer	0.000201	0.000238	CcSEcCtD
Prilocaine—Sweating—Epirubicin—hematologic cancer	0.0002	0.000238	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NCOR1—hematologic cancer	0.0002	0.00127	CbGpPWpGaD
Prilocaine—Asthenia—Gemcitabine—hematologic cancer	0.0002	0.000237	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—MAP2K1—hematologic cancer	0.000199	0.00127	CbGpPWpGaD
Prilocaine—Dizziness—Ifosfamide—hematologic cancer	0.000199	0.000236	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—CREB1—hematologic cancer	0.000198	0.00126	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—JAK1—hematologic cancer	0.000198	0.00126	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PTPRC—hematologic cancer	0.000198	0.00126	CbGpPWpGaD
Prilocaine—Vision blurred—Prednisone—hematologic cancer	0.000197	0.000234	CcSEcCtD
Prilocaine—Nausea—Thiotepa—hematologic cancer	0.000197	0.000233	CcSEcCtD
Prilocaine—Feeling abnormal—Etoposide—hematologic cancer	0.000196	0.000233	CcSEcCtD
Prilocaine—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000196	0.000232	CcSEcCtD
Prilocaine—Anaphylactic shock—Betamethasone—hematologic cancer	0.000196	0.000232	CcSEcCtD
Prilocaine—Oedema—Dexamethasone—hematologic cancer	0.000196	0.000232	CcSEcCtD
Prilocaine—Oedema—Betamethasone—hematologic cancer	0.000196	0.000232	CcSEcCtD
Prilocaine—Vomiting—Carmustine—hematologic cancer	0.000196	0.000232	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—FOXO1—hematologic cancer	0.000195	0.00124	CbGpPWpGaD
Prilocaine—Dizziness—Vincristine—hematologic cancer	0.000194	0.00023	CcSEcCtD
Prilocaine—Vomiting—Alitretinoin—hematologic cancer	0.000194	0.00023	CcSEcCtD
Prilocaine—Paraesthesia—Triamcinolone—hematologic cancer	0.000194	0.00023	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—IL6R—hematologic cancer	0.000194	0.00123	CbGpPWpGaD
Prilocaine—Drowsiness—Doxorubicin—hematologic cancer	0.000193	0.000229	CcSEcCtD
Prilocaine—Feeling abnormal—Prednisolone—hematologic cancer	0.000193	0.000229	CcSEcCtD
Prilocaine—Anaemia—Prednisone—hematologic cancer	0.000193	0.000229	CcSEcCtD
Prilocaine—Shock—Betamethasone—hematologic cancer	0.000193	0.000228	CcSEcCtD
Prilocaine—Shock—Dexamethasone—hematologic cancer	0.000193	0.000228	CcSEcCtD
Prilocaine—Nervous system disorder—Betamethasone—hematologic cancer	0.000192	0.000228	CcSEcCtD
Prilocaine—Nervous system disorder—Dexamethasone—hematologic cancer	0.000192	0.000228	CcSEcCtD
Prilocaine—Vomiting—Ifosfamide—hematologic cancer	0.000191	0.000227	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—MAP2K1—hematologic cancer	0.000191	0.00122	CbGpPWpGaD
Prilocaine—Hypersensitivity—Cisplatin—hematologic cancer	0.000191	0.000227	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—JAK1—hematologic cancer	0.000191	0.00122	CbGpPWpGaD
Prilocaine—Bradycardia—Epirubicin—hematologic cancer	0.000191	0.000227	CcSEcCtD
Prilocaine—Nausea—Thalidomide—hematologic cancer	0.00019	0.000226	CcSEcCtD
Prilocaine—Neuropathy peripheral—Doxorubicin—hematologic cancer	0.00019	0.000225	CcSEcCtD
Prilocaine—Hyperhidrosis—Betamethasone—hematologic cancer	0.000189	0.000224	CcSEcCtD
Prilocaine—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000189	0.000224	CcSEcCtD
Prilocaine—Dizziness—Irinotecan—hematologic cancer	0.000189	0.000224	CcSEcCtD
Prilocaine—Urticaria—Etoposide—hematologic cancer	0.000189	0.000224	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—JAK1—hematologic cancer	0.000188	0.0012	CbGpPWpGaD
Prilocaine—Syncope—Prednisone—hematologic cancer	0.000187	0.000222	CcSEcCtD
Prilocaine—Tinnitus—Methotrexate—hematologic cancer	0.000187	0.000222	CcSEcCtD
Prilocaine—Hypoaesthesia—Epirubicin—hematologic cancer	0.000187	0.000222	CcSEcCtD
Prilocaine—Vomiting—Vincristine—hematologic cancer	0.000187	0.000221	CcSEcCtD
Prilocaine—Urticaria—Prednisolone—hematologic cancer	0.000186	0.000221	CcSEcCtD
Prilocaine—Asthenia—Cisplatin—hematologic cancer	0.000186	0.000221	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL1B—hematologic cancer	0.000186	0.00118	CbGpPWpGaD
Prilocaine—Sweating—Doxorubicin—hematologic cancer	0.000185	0.00022	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CASP3—hematologic cancer	0.000185	0.00118	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MAP2K1—hematologic cancer	0.000184	0.00117	CbGpPWpGaD
Prilocaine—Pain—Triamcinolone—hematologic cancer	0.000184	0.000219	CcSEcCtD
Prilocaine—Loss of consciousness—Prednisone—hematologic cancer	0.000184	0.000218	CcSEcCtD
Prilocaine—Hypotension—Dexamethasone—hematologic cancer	0.000183	0.000217	CcSEcCtD
Prilocaine—Hypotension—Betamethasone—hematologic cancer	0.000183	0.000217	CcSEcCtD
Prilocaine—Nausea—Carmustine—hematologic cancer	0.000183	0.000217	CcSEcCtD
Prilocaine—Vomiting—Mitoxantrone—hematologic cancer	0.000182	0.000216	CcSEcCtD
Prilocaine—Vomiting—Irinotecan—hematologic cancer	0.000182	0.000216	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—JAK2—hematologic cancer	0.000182	0.00115	CbGpPWpGaD
Prilocaine—Nausea—Alitretinoin—hematologic cancer	0.000181	0.000215	CcSEcCtD
Prilocaine—Hypertension—Prednisone—hematologic cancer	0.00018	0.000214	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—JUN—hematologic cancer	0.00018	0.00115	CbGpPWpGaD
Prilocaine—Nausea—Ifosfamide—hematologic cancer	0.000179	0.000212	CcSEcCtD
Prilocaine—Feeling abnormal—Triamcinolone—hematologic cancer	0.000178	0.000211	CcSEcCtD
Prilocaine—Anxiety—Prednisone—hematologic cancer	0.000177	0.00021	CcSEcCtD
Prilocaine—Vomiting—Gemcitabine—hematologic cancer	0.000177	0.00021	CcSEcCtD
Prilocaine—Bradycardia—Doxorubicin—hematologic cancer	0.000177	0.00021	CcSEcCtD
Prilocaine—Paraesthesia—Betamethasone—hematologic cancer	0.000176	0.000209	CcSEcCtD
Prilocaine—Paraesthesia—Dexamethasone—hematologic cancer	0.000176	0.000209	CcSEcCtD
Prilocaine—Hypersensitivity—Etoposide—hematologic cancer	0.000175	0.000208	CcSEcCtD
Prilocaine—Tinnitus—Epirubicin—hematologic cancer	0.000175	0.000208	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—JAK2—hematologic cancer	0.000174	0.00111	CbGpPWpGaD
Prilocaine—Nausea—Vincristine—hematologic cancer	0.000174	0.000207	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—MAPK14—hematologic cancer	0.000173	0.0011	CbGpPWpGaD
Prilocaine—Hypersensitivity—Prednisolone—hematologic cancer	0.000173	0.000205	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—HSP90AA1—hematologic cancer	0.000173	0.0011	CbGpPWpGaD
Prilocaine—Hypoaesthesia—Doxorubicin—hematologic cancer	0.000173	0.000205	CcSEcCtD
Prilocaine—Urticaria—Triamcinolone—hematologic cancer	0.000171	0.000203	CcSEcCtD
Prilocaine—Asthenia—Etoposide—hematologic cancer	0.000171	0.000202	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—CDK4—hematologic cancer	0.000171	0.00109	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MET—hematologic cancer	0.000171	0.00109	CbGpPWpGaD
Prilocaine—Anaphylactic shock—Prednisone—hematologic cancer	0.00017	0.000202	CcSEcCtD
Prilocaine—Oedema—Prednisone—hematologic cancer	0.00017	0.000202	CcSEcCtD
Prilocaine—Nausea—Mitoxantrone—hematologic cancer	0.00017	0.000201	CcSEcCtD
Prilocaine—Nausea—Irinotecan—hematologic cancer	0.00017	0.000201	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—JAK2—hematologic cancer	0.000168	0.00107	CbGpPWpGaD
Prilocaine—Shock—Prednisone—hematologic cancer	0.000168	0.000199	CcSEcCtD
Prilocaine—Arrhythmia—Epirubicin—hematologic cancer	0.000168	0.000199	CcSEcCtD
Prilocaine—Pain—Betamethasone—hematologic cancer	0.000167	0.000199	CcSEcCtD
Prilocaine—Pain—Dexamethasone—hematologic cancer	0.000167	0.000199	CcSEcCtD
Prilocaine—Nervous system disorder—Prednisone—hematologic cancer	0.000167	0.000198	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—MAPK14—hematologic cancer	0.000166	0.00106	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—EP300—hematologic cancer	0.000166	0.00106	CbGpPWpGaD
Prilocaine—Nausea—Gemcitabine—hematologic cancer	0.000165	0.000196	CcSEcCtD
Prilocaine—Vomiting—Cisplatin—hematologic cancer	0.000165	0.000196	CcSEcCtD
Prilocaine—Hyperhidrosis—Prednisone—hematologic cancer	0.000165	0.000196	CcSEcCtD
Prilocaine—Vision blurred—Methotrexate—hematologic cancer	0.000164	0.000195	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NOTCH1—hematologic cancer	0.000164	0.00104	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CDK4—hematologic cancer	0.000164	0.00104	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MET—hematologic cancer	0.000164	0.00104	CbGpPWpGaD
Prilocaine—Tinnitus—Doxorubicin—hematologic cancer	0.000162	0.000192	CcSEcCtD
Prilocaine—Anaemia—Methotrexate—hematologic cancer	0.000161	0.000191	CcSEcCtD
Prilocaine—Feeling abnormal—Betamethasone—hematologic cancer	0.000161	0.000191	CcSEcCtD
Prilocaine—Feeling abnormal—Dexamethasone—hematologic cancer	0.000161	0.000191	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—MAPK14—hematologic cancer	0.00016	0.00102	CbGpPWpGaD
Prilocaine—Tension—Epirubicin—hematologic cancer	0.00016	0.00019	CcSEcCtD
Prilocaine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000159	0.000189	CcSEcCtD
Prilocaine—Nervousness—Epirubicin—hematologic cancer	0.000159	0.000188	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—MET—hematologic cancer	0.000158	0.00101	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CDK4—hematologic cancer	0.000158	0.00101	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NOTCH1—hematologic cancer	0.000158	0.001	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PTPN11—hematologic cancer	0.000158	0.001	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	0.000157	0.001	CbGpPWpGaD
Prilocaine—Dizziness—Etoposide—hematologic cancer	0.000157	0.000187	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—GRB2—hematologic cancer	0.000156	0.000992	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MET—hematologic cancer	0.000156	0.00099	CbGpPWpGaD
Prilocaine—Urticaria—Dexamethasone—hematologic cancer	0.000155	0.000184	CcSEcCtD
Prilocaine—Urticaria—Betamethasone—hematologic cancer	0.000155	0.000184	CcSEcCtD
Prilocaine—Dizziness—Prednisolone—hematologic cancer	0.000155	0.000184	CcSEcCtD
Prilocaine—Arrhythmia—Doxorubicin—hematologic cancer	0.000155	0.000184	CcSEcCtD
Prilocaine—Asthenia—Triamcinolone—hematologic cancer	0.000155	0.000184	CcSEcCtD
Prilocaine—Nausea—Cisplatin—hematologic cancer	0.000154	0.000183	CcSEcCtD
Prilocaine—Vision blurred—Epirubicin—hematologic cancer	0.000154	0.000183	CcSEcCtD
Prilocaine—Paraesthesia—Prednisone—hematologic cancer	0.000153	0.000182	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—CREB1—hematologic cancer	0.000153	0.000972	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NOTCH1—hematologic cancer	0.000152	0.000968	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—PTPN11—hematologic cancer	0.000152	0.000964	CbGpPWpGaD
Prilocaine—Vomiting—Etoposide—hematologic cancer	0.000151	0.000179	CcSEcCtD
Prilocaine—Anaemia—Epirubicin—hematologic cancer	0.000151	0.000179	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—ABL1—hematologic cancer	0.00015	0.000953	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—IL6R—hematologic cancer	0.000149	0.000948	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CREBBP—hematologic cancer	0.000149	0.000947	CbGpPWpGaD
Prilocaine—Tension—Doxorubicin—hematologic cancer	0.000148	0.000176	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—CREB1—hematologic cancer	0.000147	0.000934	CbGpPWpGaD
Prilocaine—Nervousness—Doxorubicin—hematologic cancer	0.000147	0.000174	CcSEcCtD
Prilocaine—Syncope—Epirubicin—hematologic cancer	0.000146	0.000174	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—PTPN11—hematologic cancer	0.000146	0.00093	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—PTPN11—hematologic cancer	0.000144	0.000916	CbGpPWpGaD
Prilocaine—Confusional state—Methotrexate—hematologic cancer	0.000144	0.00017	CcSEcCtD
Prilocaine—Loss of consciousness—Epirubicin—hematologic cancer	0.000144	0.00017	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—IL6R—hematologic cancer	0.000143	0.000911	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CREBBP—hematologic cancer	0.000143	0.00091	CbGpPWpGaD
Prilocaine—Dizziness—Triamcinolone—hematologic cancer	0.000143	0.000169	CcSEcCtD
Prilocaine—Anaphylactic shock—Methotrexate—hematologic cancer	0.000142	0.000169	CcSEcCtD
Prilocaine—Vision blurred—Doxorubicin—hematologic cancer	0.000142	0.000169	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—MAP2K1—hematologic cancer	0.000142	0.000904	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HES1—hematologic cancer	0.000142	0.000901	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CREB1—hematologic cancer	0.000142	0.000901	CbGpPWpGaD
Prilocaine—Nausea—Etoposide—hematologic cancer	0.000141	0.000168	CcSEcCtD
Prilocaine—Hypertension—Epirubicin—hematologic cancer	0.000141	0.000167	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—NCOR1—hematologic cancer	0.000141	0.000896	CbGpPWpGaD
Prilocaine—Feeling abnormal—Prednisone—hematologic cancer	0.00014	0.000167	CcSEcCtD
Prilocaine—Asthenia—Dexamethasone—hematologic cancer	0.00014	0.000167	CcSEcCtD
Prilocaine—Asthenia—Betamethasone—hematologic cancer	0.00014	0.000167	CcSEcCtD
Prilocaine—Nervous system disorder—Methotrexate—hematologic cancer	0.00014	0.000166	CcSEcCtD
Prilocaine—Anaemia—Doxorubicin—hematologic cancer	0.00014	0.000166	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—CREB1—hematologic cancer	0.00014	0.000887	CbGpPWpGaD
Prilocaine—Nausea—Prednisolone—hematologic cancer	0.000139	0.000165	CcSEcCtD
Prilocaine—Anxiety—Epirubicin—hematologic cancer	0.000139	0.000164	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—SRC—hematologic cancer	0.000138	0.000879	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—IL6R—hematologic cancer	0.000138	0.000879	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CREBBP—hematologic cancer	0.000138	0.000877	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Methotrexate—hematologic cancer	0.000138	0.000163	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—FOXO1—hematologic cancer	0.000137	0.000873	CbGpPWpGaD
Prilocaine—Vomiting—Triamcinolone—hematologic cancer	0.000137	0.000163	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—MAP2K1—hematologic cancer	0.000137	0.000868	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—IL6R—hematologic cancer	0.000136	0.000866	CbGpPWpGaD
Prilocaine—Syncope—Doxorubicin—hematologic cancer	0.000136	0.000161	CcSEcCtD
Prilocaine—Urticaria—Prednisone—hematologic cancer	0.000135	0.000161	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—FGF2—hematologic cancer	0.000135	0.00086	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—TNF—hematologic cancer	0.000135	0.000857	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—VEGFA—hematologic cancer	0.000135	0.000856	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—JAK1—hematologic cancer	0.000134	0.000855	CbGpPWpGaD
Prilocaine—Confusional state—Epirubicin—hematologic cancer	0.000134	0.000159	CcSEcCtD
Prilocaine—Oedema—Epirubicin—hematologic cancer	0.000133	0.000158	CcSEcCtD
Prilocaine—Anaphylactic shock—Epirubicin—hematologic cancer	0.000133	0.000158	CcSEcCtD
Prilocaine—Hypotension—Methotrexate—hematologic cancer	0.000133	0.000158	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—NRAS—hematologic cancer	0.000133	0.000846	CbGpPWpGaD
Prilocaine—Loss of consciousness—Doxorubicin—hematologic cancer	0.000133	0.000158	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—SRC—hematologic cancer	0.000133	0.000844	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MAP2K1—hematologic cancer	0.000132	0.000837	CbGpPWpGaD
Prilocaine—Shock—Epirubicin—hematologic cancer	0.000131	0.000156	CcSEcCtD
Prilocaine—Nervous system disorder—Epirubicin—hematologic cancer	0.000131	0.000155	CcSEcCtD
Prilocaine—Hypertension—Doxorubicin—hematologic cancer	0.00013	0.000155	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—FGF2—hematologic cancer	0.00013	0.000826	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MAP2K1—hematologic cancer	0.00013	0.000825	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—JAK2—hematologic cancer	0.00013	0.000824	CbGpPWpGaD
Prilocaine—Dizziness—Betamethasone—hematologic cancer	0.000129	0.000154	CcSEcCtD
Prilocaine—Dizziness—Dexamethasone—hematologic cancer	0.000129	0.000154	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—VEGFA—hematologic cancer	0.000129	0.000822	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Epirubicin—hematologic cancer	0.000129	0.000153	CcSEcCtD
Prilocaine—Anxiety—Doxorubicin—hematologic cancer	0.000128	0.000152	CcSEcCtD
Prilocaine—Nausea—Triamcinolone—hematologic cancer	0.000128	0.000152	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—SRC—hematologic cancer	0.000128	0.000814	CbGpPWpGaD
Prilocaine—Paraesthesia—Methotrexate—hematologic cancer	0.000128	0.000152	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—NRAS—hematologic cancer	0.000128	0.000812	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MAPK3—hematologic cancer	0.000127	0.00081	CbGpPWpGaD
Prilocaine—Somnolence—Methotrexate—hematologic cancer	0.000127	0.00015	CcSEcCtD
Prilocaine—Hypersensitivity—Prednisone—hematologic cancer	0.000126	0.000149	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—FGF2—hematologic cancer	0.000125	0.000797	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—VEGFA—hematologic cancer	0.000125	0.000793	CbGpPWpGaD
Prilocaine—Hypotension—Epirubicin—hematologic cancer	0.000125	0.000148	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—JAK2—hematologic cancer	0.000124	0.000792	CbGpPWpGaD
Prilocaine—Vomiting—Betamethasone—hematologic cancer	0.000124	0.000148	CcSEcCtD
Prilocaine—Vomiting—Dexamethasone—hematologic cancer	0.000124	0.000148	CcSEcCtD
Prilocaine—Confusional state—Doxorubicin—hematologic cancer	0.000124	0.000148	CcSEcCtD
Prilocaine—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000123	0.000146	CcSEcCtD
Prilocaine—Oedema—Doxorubicin—hematologic cancer	0.000123	0.000146	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—NRAS—hematologic cancer	0.000123	0.000783	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MAPK3—hematologic cancer	0.000122	0.000778	CbGpPWpGaD
Prilocaine—Asthenia—Prednisone—hematologic cancer	0.000122	0.000145	CcSEcCtD
Prilocaine—Pain—Methotrexate—hematologic cancer	0.000122	0.000145	CcSEcCtD
Prilocaine—Shock—Doxorubicin—hematologic cancer	0.000121	0.000144	CcSEcCtD
Prilocaine—Nervous system disorder—Doxorubicin—hematologic cancer	0.000121	0.000144	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—JAK2—hematologic cancer	0.00012	0.000763	CbGpPWpGaD
Prilocaine—Paraesthesia—Epirubicin—hematologic cancer	0.00012	0.000142	CcSEcCtD
Prilocaine—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000119	0.000141	CcSEcCtD
Prilocaine—Somnolence—Epirubicin—hematologic cancer	0.000119	0.000141	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—JAK2—hematologic cancer	0.000118	0.000752	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MAPK3—hematologic cancer	0.000118	0.00075	CbGpPWpGaD
Prilocaine—Feeling abnormal—Methotrexate—hematologic cancer	0.000117	0.000139	CcSEcCtD
Prilocaine—Nausea—Betamethasone—hematologic cancer	0.000116	0.000138	CcSEcCtD
Prilocaine—Nausea—Dexamethasone—hematologic cancer	0.000116	0.000138	CcSEcCtD
Prilocaine—Hypotension—Doxorubicin—hematologic cancer	0.000115	0.000137	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—KRAS—hematologic cancer	0.000114	0.000728	CbGpPWpGaD
Prilocaine—Pain—Epirubicin—hematologic cancer	0.000114	0.000135	CcSEcCtD
Prilocaine—Urticaria—Methotrexate—hematologic cancer	0.000113	0.000134	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—MAPK14—hematologic cancer	0.000113	0.000717	CbGpPWpGaD
Prilocaine—Dizziness—Prednisone—hematologic cancer	0.000113	0.000134	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—MET—hematologic cancer	0.000111	0.000707	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CDK4—hematologic cancer	0.000111	0.000707	CbGpPWpGaD
Prilocaine—Paraesthesia—Doxorubicin—hematologic cancer	0.000111	0.000131	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—KRAS—hematologic cancer	0.00011	0.000699	CbGpPWpGaD
Prilocaine—Feeling abnormal—Epirubicin—hematologic cancer	0.00011	0.00013	CcSEcCtD
Prilocaine—Somnolence—Doxorubicin—hematologic cancer	0.00011	0.00013	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL6—hematologic cancer	0.000109	0.000692	CbGpPWpGaD
Prilocaine—Vomiting—Prednisone—hematologic cancer	0.000108	0.000129	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—NOTCH1—hematologic cancer	0.000107	0.00068	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—KRAS—hematologic cancer	0.000106	0.000674	CbGpPWpGaD
Prilocaine—Urticaria—Epirubicin—hematologic cancer	0.000106	0.000126	CcSEcCtD
Prilocaine—Pain—Doxorubicin—hematologic cancer	0.000105	0.000125	CcSEcCtD
Prilocaine—Hypersensitivity—Methotrexate—hematologic cancer	0.000105	0.000125	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—PTPN11—hematologic cancer	0.000103	0.000654	CbGpPWpGaD
Prilocaine—Asthenia—Methotrexate—hematologic cancer	0.000102	0.000121	CcSEcCtD
Prilocaine—Feeling abnormal—Doxorubicin—hematologic cancer	0.000102	0.000121	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—EP300—hematologic cancer	0.000101	0.000645	CbGpPWpGaD
Prilocaine—Nausea—Prednisone—hematologic cancer	0.000101	0.00012	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—CREB1—hematologic cancer	9.96e-05	0.000633	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—SRC—hematologic cancer	9.86e-05	0.000627	CbGpPWpGaD
Prilocaine—Hypersensitivity—Epirubicin—hematologic cancer	9.82e-05	0.000117	CcSEcCtD
Prilocaine—Urticaria—Doxorubicin—hematologic cancer	9.8e-05	0.000116	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—EP300—hematologic cancer	9.74e-05	0.00062	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—HRAS—hematologic cancer	9.73e-05	0.000619	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—IL6R—hematologic cancer	9.71e-05	0.000618	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CREBBP—hematologic cancer	9.7e-05	0.000617	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—VEGFA—hematologic cancer	9.6e-05	0.000611	CbGpPWpGaD
Prilocaine—Asthenia—Epirubicin—hematologic cancer	9.56e-05	0.000113	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—STAT3—hematologic cancer	9.51e-05	0.000605	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NRAS—hematologic cancer	9.49e-05	0.000603	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—SRC—hematologic cancer	9.47e-05	0.000603	CbGpPWpGaD
Prilocaine—Dizziness—Methotrexate—hematologic cancer	9.42e-05	0.000112	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—EP300—hematologic cancer	9.39e-05	0.000598	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—HRAS—hematologic cancer	9.34e-05	0.000594	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—IL6—hematologic cancer	9.31e-05	0.000592	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MAP2K1—hematologic cancer	9.26e-05	0.000589	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—VEGFA—hematologic cancer	9.23e-05	0.000587	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—STAT3—hematologic cancer	9.14e-05	0.000581	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—SRC—hematologic cancer	9.14e-05	0.000581	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NRAS—hematologic cancer	9.11e-05	0.00058	CbGpPWpGaD
Prilocaine—Hypersensitivity—Doxorubicin—hematologic cancer	9.09e-05	0.000108	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—MAPK3—hematologic cancer	9.09e-05	0.000578	CbGpPWpGaD
Prilocaine—Vomiting—Methotrexate—hematologic cancer	9.06e-05	0.000107	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—HRAS—hematologic cancer	9.01e-05	0.000573	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—SRC—hematologic cancer	9e-05	0.000572	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—IL6—hematologic cancer	8.94e-05	0.000569	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—VEGFA—hematologic cancer	8.9e-05	0.000566	CbGpPWpGaD
Prilocaine—Asthenia—Doxorubicin—hematologic cancer	8.85e-05	0.000105	CcSEcCtD
Prilocaine—Dizziness—Epirubicin—hematologic cancer	8.81e-05	0.000105	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—TGFB1—hematologic cancer	8.81e-05	0.000561	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—STAT3—hematologic cancer	8.81e-05	0.00056	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—FGF2—hematologic cancer	8.8e-05	0.00056	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NRAS—hematologic cancer	8.79e-05	0.000559	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—VEGFA—hematologic cancer	8.77e-05	0.000558	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MAPK3—hematologic cancer	8.73e-05	0.000555	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—NRAS—hematologic cancer	8.66e-05	0.000551	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—IL6—hematologic cancer	8.62e-05	0.000549	CbGpPWpGaD
Prilocaine—Vomiting—Epirubicin—hematologic cancer	8.48e-05	0.000101	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—TGFB1—hematologic cancer	8.47e-05	0.000539	CbGpPWpGaD
Prilocaine—Nausea—Methotrexate—hematologic cancer	8.46e-05	0.0001	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—JAK2—hematologic cancer	8.44e-05	0.000537	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MAPK3—hematologic cancer	8.42e-05	0.000535	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MAPK3—hematologic cancer	8.29e-05	0.000527	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—TNF—hematologic cancer	8.23e-05	0.000524	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—TGFB1—hematologic cancer	8.17e-05	0.000519	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KRAS—hematologic cancer	8.16e-05	0.000519	CbGpPWpGaD
Prilocaine—Dizziness—Doxorubicin—hematologic cancer	8.16e-05	9.68e-05	CcSEcCtD
Prilocaine—Nausea—Epirubicin—hematologic cancer	7.92e-05	9.39e-05	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—TNF—hematologic cancer	7.91e-05	0.000503	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KRAS—hematologic cancer	7.84e-05	0.000499	CbGpPWpGaD
Prilocaine—Vomiting—Doxorubicin—hematologic cancer	7.84e-05	9.31e-05	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—TNF—hematologic cancer	7.63e-05	0.000485	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KRAS—hematologic cancer	7.56e-05	0.000481	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KRAS—hematologic cancer	7.45e-05	0.000474	CbGpPWpGaD
Prilocaine—Nausea—Doxorubicin—hematologic cancer	7.33e-05	8.69e-05	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—HRAS—hematologic cancer	6.94e-05	0.000441	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—HRAS—hematologic cancer	6.67e-05	0.000424	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—IL6—hematologic cancer	6.64e-05	0.000423	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—EP300—hematologic cancer	6.6e-05	0.00042	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—HRAS—hematologic cancer	6.43e-05	0.000409	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—SRC—hematologic cancer	6.42e-05	0.000409	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—IL6—hematologic cancer	6.38e-05	0.000406	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—HRAS—hematologic cancer	6.33e-05	0.000403	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—VEGFA—hematologic cancer	6.26e-05	0.000398	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—STAT3—hematologic cancer	6.19e-05	0.000394	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NRAS—hematologic cancer	6.18e-05	0.000393	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—IL6—hematologic cancer	6.15e-05	0.000391	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—AKT1—hematologic cancer	6.13e-05	0.00039	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—IL6—hematologic cancer	6.06e-05	0.000386	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MAPK3—hematologic cancer	5.92e-05	0.000376	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—AKT1—hematologic cancer	5.89e-05	0.000374	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—TGFB1—hematologic cancer	5.74e-05	0.000365	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—AKT1—hematologic cancer	5.68e-05	0.000361	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—TNF—hematologic cancer	5.36e-05	0.000341	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KRAS—hematologic cancer	5.32e-05	0.000338	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HRAS—hematologic cancer	4.52e-05	0.000288	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—IL6—hematologic cancer	4.33e-05	0.000275	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—AKT1—hematologic cancer	3.99e-05	0.000254	CbGpPWpGaD
